HCPC
ELV icon

Hamilton Capital Partners (Canada)’s Elevance Health ELV Stock Holding History

Hamilton Capital Partners (Canada)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,397
Closed -$4.43M – 222
2025
Q2 		$4.43M Buy
11,397
+2,077
+22% +$835K 0.23% 88
2025
Q1 		$4.05M Buy
9,320
+1,937
+26% +$778K 0.26% 82
2024
Q4 		$2.72M Sell
7,383
-798
-10% -$334K 0.2% 94
2024
Q3 		$4.25M Sell
8,181
-1,050
-11% -$561K 0.37% 73
2024
Q2 		$5M Buy
9,231
+514
+6% +$272K 0.54% 57
2024
Q1 		$4.52M Buy
+8,717
New +$4.34M 0.55% 61

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Hamilton Capital Partners (Canada)'s ELV Position: Q3 2025 in Review

Hamilton Capital Partners (Canada) sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 11,397 shares — an estimated $4.43M sold.

Hamilton Capital Partners (Canada) first reported a position in ELV in Q1 2024 and held it in 6 quarters. The position peaked at $5M in Q2 2024. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Hamilton Capital Partners (Canada) reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Hamilton Capital Partners (Canada) sold 11,397 Elevance Health shares in Q3 2025, an estimated $4.43M.
  • Hamilton Capital Partners (Canada) first reported a position in Elevance Health in Q1 2024 and held it in 6 quarters.
  • Hamilton Capital Partners (Canada)'s Elevance Health position peaked at $5M in Q2 2024.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q3 2025, filed 14 Aug 2026.